{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T23:09:05Z","timestamp":1777590545835,"version":"3.51.4"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,8,3]],"date-time":"2019-08-03T00:00:00Z","timestamp":1564790400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,8,3]],"date-time":"2019-08-03T00:00:00Z","timestamp":1564790400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Osteoporos Int"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1007\/s00198-019-05082-8","type":"journal-article","created":{"date-parts":[[2019,8,3]],"date-time":"2019-08-03T15:02:25Z","timestamp":1564844545000},"page":"59-66","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Systematic review of the effects of bisphosphonates on bone density and fracture incidence in childhood acute lymphoblastic leukaemia"],"prefix":"10.1007","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3179-729X","authenticated-orcid":false,"given":"A. M.","family":"Harris","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. R.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S. C.","family":"Wong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,8,3]]},"reference":[{"key":"5082_CR1","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1002\/pbc.20701","volume":"48","author":"W Hogler","year":"2007","unstructured":"Hogler W, Wehl G, van Staa T, Meister B, Klein-Franke A, Kropshofer G (2007) Incidence of skeletal complications during treatment of childhood acute lymphoblastic leukemia: comparison of fracture risk with the general practice research database. Pediatr Blood Cancer 48:21\u201327","journal-title":"Pediatr Blood Cancer"},{"key":"5082_CR2","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.bone.2013.11.017","volume":"59","author":"ML te Winkel","year":"2014","unstructured":"te Winkel ML, Pieters R, Hop WC et al (2014) Bone mineral density at diagnosis determines fracture rate in children with acute lymphoblastic leukemia treated according to the DCOG-ALL9 protocol. Bone 59:223\u2013228","journal-title":"Bone"},{"key":"5082_CR3","doi-asserted-by":"publisher","first-page":"3066","DOI":"10.1200\/JCO.2001.19.12.3066","volume":"19","author":"AJ Strauss","year":"2001","unstructured":"Strauss AJ, Su JT, Dalton VM, Gelber RD, Sallan SE, Silverman LB (2001) Bony morbidity in children treated for acute lymphoblastic leukemia. J Clin Oncol 19:3066\u20133072","journal-title":"J Clin Oncol"},{"key":"5082_CR4","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.jocd.2014.01.007","volume":"17","author":"CM Gordon","year":"2014","unstructured":"Gordon CM, Leonard MB, Zemel BS, International Society for Clinical D (2014) 2013 pediatric position development conference: executive summary and reflections. J Clin Densitom 17:219\u2013224","journal-title":"J Clin Densitom"},{"key":"5082_CR5","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.1359\/jbmr.090202","volume":"24","author":"J Halton","year":"2009","unstructured":"Halton J, Gaboury I, Grant R, Alos N, Cummings EA, Matzinger M, Shenouda N, Lentle B, Abish S, Atkinson S, Cairney E, Dix D, Israels S, Stephure D, Wilson B, Hay J, Moher D, Rauch F, Siminoski K, Ward LM, and the Canadian STOPP Consortium (2009) Advanced vertebral fracture among newly diagnosed children with acute lymphoblastic leukemia: results of the Canadian Steroid-Associated Osteoporosis in the Pediatric Population (STOPP) research program. J Bone Miner Res 24:1326\u20131334","journal-title":"J Bone Miner Res"},{"key":"5082_CR6","doi-asserted-by":"publisher","first-page":"2760","DOI":"10.1200\/JCO.2011.40.4830","volume":"30","author":"N Alos","year":"2012","unstructured":"Alos N, Grant RM, Ramsay T, Halton J, Cummings EA, Miettunen PM, Abish S, Atkinson S, Barr R, Cabral DA, Cairney E, Couch R, Dix DB, Fernandez CV, Hay J, Israels S, Laverdi\u00e8re C, Lentle B, Lewis V, Matzinger MA, Rodd C, Shenouda N, Stein R, Stephure D, Taback S, Wilson B, Williams K, Rauch F, Siminoski K, Ward LM (2012) High incidence of vertebral fractures in children with acute lymphoblastic leukemia 12 months after the initiation of therapy. J Clin Oncol 30:2760\u20132767","journal-title":"J Clin Oncol"},{"key":"5082_CR7","doi-asserted-by":"publisher","first-page":"3408","DOI":"10.1210\/JC.2015-2176","volume":"100","author":"EA Cummings","year":"2015","unstructured":"Cummings EA, Ma J, Fernandez CV, Halton J, Alos N, Miettunen PM, Jaremko JL, Ho J, Shenouda N, Matzinger MA, Lentle B, Stephure D, Stein R, Sbrocchi AM, Rodd C, Lang B, Israels S, Grant RM, Couch R, Barr R, Hay J, Rauch F, Siminoski K, Ward LM, the Canadian STOPP Consortium (National Pediatric Bone Health Working Group) (2015) Incident vertebral fractures in children with leukemia during the four years following diagnosis. J Clin Endocrinol Metab 100:3408\u20133417","journal-title":"J Clin Endocrinol Metab"},{"key":"5082_CR8","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1002\/pbc.25942","volume":"63","author":"LC Dal Osto","year":"2016","unstructured":"Dal Osto LC, Konji VN, Halton J, Matzinger MA, Bassal M, Rauch F, Ward LM (2016) The spectrum of recovery from fracture-induced vertebral deformity in pediatric leukemia. Pediatr Blood Cancer 63:1107\u20131110","journal-title":"Pediatr Blood Cancer"},{"key":"5082_CR9","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1002\/jbmr.3447","volume":"33","author":"LM Ward","year":"2018","unstructured":"Ward LM, Ma J, Lang B, Ho J, Alos N, Matzinger MA, Shenouda N, Lentle B, Jaremko JL, Wilson B, Stephure D, Stein R, Sbrocchi AM, Rodd C, Lewis V, Israels S, Grant RM, Fernandez CV, Dix DB, Cummings EA, Couch R, Cairney E, Barr R, Abish S, Atkinson SA, Hay J, Rauch F, Moher D, Siminoski K, Halton J, the Steroid-Associated Osteoporosis in the Pediatric Population (STOPP) Consortium (2018) Bone morbidity and recovery in children with acute lymphoblastic leukemia: results of a six-year prospective cohort study. J Bone Miner Res 33:1435\u20131443","journal-title":"J Bone Miner Res"},{"key":"5082_CR10","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1203\/00006450-199904010-00014","volume":"45","author":"JT Warner","year":"1999","unstructured":"Warner JT, Evans WD, Webb DK, Bell W, Gregory JW (1999) Relative osteopenia after treatment for acute lymphoblastic leukemia. Pediatr Res 45:544\u2013551","journal-title":"Pediatr Res"},{"key":"5082_CR11","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1097\/00043426-199805000-00009","volume":"20","author":"P Arikoski","year":"1998","unstructured":"Arikoski P, Komulainen J, Voutilainen R, Riikonen P, Parviainen M, Tapanainen P, Knip M, Kroger H (1998) Reduced bone mineral density in long-term survivors of childhood acute lymphoblastic leukemia. J Pediatr Hematol Oncol 20:234\u2013240","journal-title":"J Pediatr Hematol Oncol"},{"key":"5082_CR12","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1359\/jbmr.2002.17.6.1073","volume":"17","author":"V Tillmann","year":"2002","unstructured":"Tillmann V, Darlington AS, Eiser C, Bishop NJ, Davies HA (2002) Male sex and low physical activity are associated with reduced spine bone mineral density in survivors of childhood acute lymphoblastic leukemia. J Bone Miner Res 17:1073\u20131080","journal-title":"J Bone Miner Res"},{"key":"5082_CR13","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1067\/mpd.2001.113102","volume":"138","author":"N Kadan-Lottick","year":"2001","unstructured":"Kadan-Lottick N, Marshall JA, Baron AE, Krebs NF, Hambidge KM, Albano E (2001) Normal bone mineral density after treatment for childhood acute lymphoblastic leukemia diagnosed between 1991 and 1998. J Pediatr 138:898\u2013904","journal-title":"J Pediatr"},{"key":"5082_CR14","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1002\/1096-911X(20001001)35:4<415::AID-MPO4>3.0.CO;2-9","volume":"35","author":"IM van der Sluis","year":"2000","unstructured":"van der Sluis IM, van den Heuvel-Eibrink MM, Hahlen K, Krenning EP, de Muinck Keizer-Schrama SM (2000) Bone mineral density, body composition, and height in long-term survivors of acute lymphoblastic leukemia in childhood. Med Pediatr Oncol 35:415\u2013420","journal-title":"Med Pediatr Oncol"},{"key":"5082_CR15","doi-asserted-by":"publisher","first-page":"571","DOI":"10.2174\/1566524023362104","volume":"2","author":"GA Rodan","year":"2002","unstructured":"Rodan GA, Reszka AA (2002) Bisphosphonate mechanism of action. Curr Mol Med 2:571\u2013577","journal-title":"Curr Mol Med"},{"key":"5082_CR16","doi-asserted-by":"publisher","first-page":"2147","DOI":"10.1007\/s00198-016-3515-9","volume":"27","author":"LM Ward","year":"2016","unstructured":"Ward LM, Konji VN, Ma J (2016) The management of osteoporosis in children. Osteoporos Int 27:2147\u20132179","journal-title":"Osteoporos Int"},{"key":"5082_CR17","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1111\/jpc.13768","volume":"54","author":"PJ Simm","year":"2018","unstructured":"Simm PJ, Biggin A, Zacharin MR, Rodda CP, Tham E, Siafarikas A, Jefferies C, Hofman PL, Jensen DE, Woodhead H, Brown J, Wheeler BJ, Brookes D, Lafferty A, Munns CF, on behalf of the APEG Bone Mineral Working Group (2018) Consensus guidelines on the use of bisphosphonate therapy in children and adolescents. J Paediatr Child Health 54:223\u2013233","journal-title":"J Paediatr Child Health"},{"key":"5082_CR18","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1159\/000447583","volume":"86","author":"S Joseph","year":"2016","unstructured":"Joseph S, McCarrison S, Wong SC (2016) Skeletal fragility in children with chronic disease. Horm Res Paediatr 86:71\u201382","journal-title":"Horm Res Paediatr"},{"key":"5082_CR19","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1080\/08880010500198285","volume":"22","author":"EB Goldbloom","year":"2005","unstructured":"Goldbloom EB, Cummings EA, Yhap M (2005) Osteoporosis at presentation of childhood ALL: management with pamidronate. Pediatr Hematol Oncol 22:543\u2013550","journal-title":"Pediatr Hematol Oncol"},{"key":"5082_CR20","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1002\/pbc.24563","volume":"60","author":"B Padhye","year":"2013","unstructured":"Padhye B, Dalla-Pozza L, Little DG, Munns CF (2013) Use of zoledronic acid for treatment of chemotherapy related osteonecrosis in children and adolescents: a retrospective analysis. Pediatr Blood Cancer 60:1539\u20131545","journal-title":"Pediatr Blood Cancer"},{"key":"5082_CR21","doi-asserted-by":"publisher","first-page":"99","DOI":"10.5045\/br.2013.48.2.99","volume":"48","author":"JM Lee","year":"2013","unstructured":"Lee JM, Kim JE, Bae SH, Hah JO (2013) Efficacy of pamidronate in children with low bone mineral density during and after chemotherapy for acute lymphoblastic leukemia and non-Hodgkin lymphoma. Blood Res 48:99\u2013106","journal-title":"Blood Res"},{"key":"5082_CR22","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1191\/1078155205jp145oa","volume":"11","author":"JT Wiernikowski","year":"2005","unstructured":"Wiernikowski JT, Barr RD, Webber C, Guo CY, Wright M, Atkinson SA (2005) Alendronate for steroid-induced osteopenia in children with acute lymphoblastic leukaemia or non-Hodgkin's lymphoma: results of a pilot study. J Oncol Pharm Pract 11:51\u201356","journal-title":"J Oncol Pharm Pract"},{"key":"5082_CR23","doi-asserted-by":"publisher","first-page":"e705","DOI":"10.1542\/peds.2007-1396","volume":"121","author":"K Wasilewski-Masker","year":"2008","unstructured":"Wasilewski-Masker K, Kaste SC, Hudson MM, Esiashvili N, Mattano LA, Meacham LR (2008) Bone mineral density deficits in survivors of childhood cancer: long-term follow-up guidelines and review of the literature. Pediatrics 121:e705\u2013e713","journal-title":"Pediatrics"},{"key":"5082_CR24","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1002\/cncr.22546","volume":"109","author":"A Sala","year":"2007","unstructured":"Sala A, Barr RD (2007) Osteopenia and cancer in children and adolescents: the fragility of success. Cancer 109:1420\u20131431","journal-title":"Cancer"},{"key":"5082_CR25","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1016\/j.ejca.2006.11.002","volume":"43","author":"A Sala","year":"2007","unstructured":"Sala A, Mattano LA Jr, Barr RD (2007) Osteonecrosis in children and adolescents with cancer - an adverse effect of systemic therapy. Eur J Cancer 43:683\u2013689","journal-title":"Eur J Cancer"},{"key":"5082_CR26","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1002\/mpo.10057","volume":"39","author":"RD Barr","year":"2002","unstructured":"Barr RD, Guo CY, Wiernikowski J, Webber C, Wright M, Atkinson S (2002) Osteopenia in children with acute lymphoblastic leukemia: a pilot study of amelioration with Pamidronate. Med Pediatr Oncol 39:44\u201346","journal-title":"Med Pediatr Oncol"},{"key":"5082_CR27","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1097\/MPH.0b013e318142b7a1","volume":"29","author":"C Lethaby","year":"2007","unstructured":"Lethaby C, Wiernikowski J, Sala A, Naronha M, Webber C, Barr RD (2007) Bisphosphonate therapy for reduced bone mineral density during treatment of acute lymphoblastic leukemia in childhood and adolescence: a report of preliminary experience. J Pediatr Hematol Oncol 29:613\u2013616","journal-title":"J Pediatr Hematol Oncol"},{"key":"5082_CR28","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1111\/j.1440-1754.2005.00720.x","volume":"41","author":"JJ Brown","year":"2005","unstructured":"Brown JJ, Zacharin MR (2005) Attempted randomized controlled trial of pamidronate versus calcium and calcitriol supplements for management of steroid-induced osteoporosis in children and adolescents. J Paediatr Child Health 41:580\u2013582","journal-title":"J Paediatr Child Health"},{"key":"5082_CR29","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.bone.2019.01.003","volume":"121","author":"N Nasomyont","year":"2019","unstructured":"Nasomyont N, Hornung LN, Gordon CM, Wasserman H (2019) Outcomes following intravenous bisphosphonate infusion in pediatric patients: a 7-year retrospective chart review. Bone 121:60\u201367","journal-title":"Bone"},{"key":"5082_CR30","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.jocd.2014.01.003","volume":"17","author":"NJ Crabtree","year":"2014","unstructured":"Crabtree NJ, Arabi A, Bachrach LK, Fewtrell M, El-Hajj Fuleihan G, Kecskemethy HH, Jaworski M, Gordon CM, International Society for Clinical D (2014) Dual-energy X-ray absorptiometry interpretation and reporting in children and adolescents: the revised 2013 ISCD pediatric official positions. J Clin Densitom 17:225\u2013242","journal-title":"J Clin Densitom"},{"key":"5082_CR31","first-page":"3121","volume":"83","author":"PM Crofton","year":"1998","unstructured":"Crofton PM, Ahmed SF, Wade JC, Stephen R, Elmlinger MW, Ranke MB, Kelnar CJ, Wallace WH (1998) Effects of intensive chemotherapy on bone and collagen turnover and the growth hormone axis in children with acute lymphoblastic leukemia. J Clin Endocrinol Metab 83:3121\u20133129","journal-title":"J Clin Endocrinol Metab"},{"key":"5082_CR32","doi-asserted-by":"publisher","first-page":"3174","DOI":"10.1210\/jcem.84.9.5968","volume":"84","author":"P Arikoski","year":"1999","unstructured":"Arikoski P, Komulainen J, Riikonen P, Voutilainen R, Knip M, Kroger H (1999) Alterations in bone turnover and impaired development of bone mineral density in newly diagnosed children with cancer: a 1-year prospective study. J Clin Endocrinol Metab 84:3174\u20133181","journal-title":"J Clin Endocrinol Metab"},{"key":"5082_CR33","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1007\/s11914-018-0434-z","volume":"16","author":"LM Ward","year":"2018","unstructured":"Ward LM, Rauch F (2018) Anabolic therapy for the treatment of osteoporosis in childhood. Curr Osteoporos Rep 16:269\u2013276","journal-title":"Curr Osteoporos Rep"}],"container-title":["Osteoporosis International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-019-05082-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00198-019-05082-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-019-05082-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T23:17:25Z","timestamp":1596323845000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00198-019-05082-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,3]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,1]]}},"alternative-id":["5082"],"URL":"https:\/\/doi.org\/10.1007\/s00198-019-05082-8","relation":{},"ISSN":["0937-941X","1433-2965"],"issn-type":[{"value":"0937-941X","type":"print"},{"value":"1433-2965","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,8,3]]},"assertion":[{"value":"22 January 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 August 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"SCW has received consultancy fees from Novartis.The rest of the authors have no conflict of interest to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}